These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 28089386

  • 1. Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma.
    Li G, Zhao A, Péoch M, Cottier M, Mottet N.
    Urol Oncol; 2017 May; 35(5):294-299. PubMed ID: 28089386
    [Abstract] [Full Text] [Related]

  • 2. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
    Zhang W, Ni M, Su Y, Wang H, Zhu S, Zhao A, Li G.
    Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
    [Abstract] [Full Text] [Related]

  • 3. Evaluating the Urinary Exosome microRNA Profile of von Hippel Lindau Syndrome Patients with Clear Cell Renal Cell Carcinoma.
    Walter-Rodriguez B, Ricketts CJ, Linehan WM, Merino MJ.
    Genes (Basel); 2024 Jul 11; 15(7):. PubMed ID: 39062684
    [Abstract] [Full Text] [Related]

  • 4. Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma.
    Cochetti G, Cari L, Nocentini G, Maulà V, Suvieri C, Cagnani R, Rossi De Vermandois JA, Mearini E.
    Sci Rep; 2020 Dec 04; 10(1):21290. PubMed ID: 33277569
    [Abstract] [Full Text] [Related]

  • 5. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
    Lou N, Ruan AM, Qiu B, Bao L, Xu YC, Zhao Y, Sun RL, Zhang ST, Xu GH, Ruan HL, Yuan CF, Han WW, Shi HC, Yang HM, Zhang XP.
    Urol Oncol; 2017 Jan 04; 35(1):36.e7-36.e14. PubMed ID: 27633984
    [Abstract] [Full Text] [Related]

  • 6. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5.
    Song S, Long M, Yu G, Cheng Y, Yang Q, Liu J, Wang Y, Sheng J, Wang L, Wang Z, Xu B.
    J Cell Mol Med; 2019 Oct 04; 23(10):6755-6765. PubMed ID: 31342628
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
    Mytsyk Y, Dosenko V, Borys Y, Kucher A, Gazdikova K, Busselberg D, Caprnda M, Kruzliak P, Farooqi AA, Lubov M.
    Int Urol Nephrol; 2018 May 04; 50(5):851-859. PubMed ID: 29549624
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-30a-5pme: a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples.
    Outeiro-Pinho G, Barros-Silva D, Aznar E, Sousa AI, Vieira-Coimbra M, Oliveira J, Gonçalves CS, Costa BM, Junker K, Henrique R, Jerónimo C.
    J Exp Clin Cancer Res; 2020 Jun 01; 39(1):98. PubMed ID: 32487203
    [Abstract] [Full Text] [Related]

  • 9. Emerging role of secreted miR-210-3p as potential biomarker for clear cell Renal Cell Carcinoma metastasis.
    Petrozza V, Costantini M, Tito C, Giammusso LM, Sorrentino V, Cacciotti J, Porta N, Iaiza A, Pastore AL, Di Carlo A, Simone G, Carbone A, Gallucci M, Fazi F.
    Cancer Biomark; 2020 Jun 01; 27(2):181-188. PubMed ID: 31771042
    [Abstract] [Full Text] [Related]

  • 10. Prognostic urinary miRNAs for the assessment of small renal masses.
    Di Meo A, Brown MD, Finelli A, Jewett MAS, Diamandis EP, Yousef GM.
    Clin Biochem; 2020 Jan 01; 75():15-22. PubMed ID: 31672647
    [Abstract] [Full Text] [Related]

  • 11. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.
    Fedorko M, Juracek J, Stanik M, Svoboda M, Poprach A, Buchler T, Pacik D, Dolezel J, Slaby O.
    Biochem Med (Zagreb); 2017 Jun 15; 27(2):411-417. PubMed ID: 28694731
    [Abstract] [Full Text] [Related]

  • 12. Cell-free RNA content in urine as a possible molecular diagnostic tool for clear cell renal cell carcinoma.
    Zhao A, Péoc'h M, Cottier M, Genin C, Mottet N, Li G.
    Int J Cancer; 2015 Jun 01; 136(11):2610-5. PubMed ID: 25379634
    [Abstract] [Full Text] [Related]

  • 13. Serum microRNA Expression Profiling: Potential Diagnostic Implications of a Panel of Serum microRNAs for Clear Cell Renal Cell Cancer.
    Yadav S, Khandelwal M, Seth A, Saini AK, Dogra PN, Sharma A.
    Urology; 2017 Jun 01; 104():64-69. PubMed ID: 28336290
    [Abstract] [Full Text] [Related]

  • 14. Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma.
    Sato T, Kawasaki Y, Maekawa M, Takasaki S, Shimada S, Morozumi K, Sato M, Kawamorita N, Yamashita S, Mitsuzuka K, Mano N, Ito A.
    Cancer Sci; 2020 Jul 01; 111(7):2570-2578. PubMed ID: 32350988
    [Abstract] [Full Text] [Related]

  • 15. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
    Liu S, Deng X, Zhang J.
    Mol Med Rep; 2019 Dec 01; 20(6):5075-5083. PubMed ID: 31661117
    [Abstract] [Full Text] [Related]

  • 16. Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles.
    Grützmann K, Salomo K, Krüger A, Lohse-Fischer A, Erdmann K, Seifert M, Baretton G, Aust D, William D, Schröck E, Thomas C, Füssel S.
    Biol Direct; 2024 May 13; 19(1):38. PubMed ID: 38741178
    [Abstract] [Full Text] [Related]

  • 17. Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients.
    Zununi Vahed S, Omidi Y, Ardalan M, Samadi N.
    Clin Biochem; 2017 Jan 13; 50(1-2):32-39. PubMed ID: 27521993
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
    Zhang X, Zhang Y, Liu X, Fang A, Wang J, Yang Y, Wang L, Du L, Wang C.
    Oncotarget; 2016 Jan 19; 7(3):3255-66. PubMed ID: 26657502
    [Abstract] [Full Text] [Related]

  • 20. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X, Wang X, Ruan A, Han W, Zhao Y, Lu X, Xiao P, Shi H, Wang R, Chen L, Chen S, Du Q, Yang H, Zhang X.
    Clin Cancer Res; 2014 May 15; 20(10):2617-30. PubMed ID: 24647573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.